Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Launched by NATIONAL CANCER INSTITUTE (NCI) · Nov 14, 2001

Keywords

ClinConnect Summary

This clinical trial is focused on collecting blood and tissue samples from patients who have been diagnosed with or are suspected of having certain types of cancer, including kidney and bladder cancer. The goal of the study is to gather these samples to help researchers at the Urologic Oncology Branch of the National Cancer Institute (NCI) better understand cancer and improve treatment options in the future.

To participate in this trial, individuals must be at least 2 years old and either have a confirmed diagnosis of cancer from a biopsy or be suspected of having cancer. Family members of patients with cancer or inherited cancer syndromes can also participate. During the initial visit, blood samples will be collected, and additional samples may be taken at later visits or during surgery. All samples will be stored securely for future research. Before joining the study, participants and their guardians (if applicable) will need to sign a consent form to confirm they understand the study and any potential risks involved.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Adult and minor patients with biopsy-proven malignant disease
• • Adult and minor patients suspected of having a malignant disease
• • Patients who have or are suspected of having an inherited genitourinary malignant disorder
• • Participants must be \>= 2 years of age
• • Family members (related by blood) of patients who have or are suspected of having a malignant disease or an inherited genitourinary malignant disorder.
• • All patients and guardians, for children younger than 18 years of age, must sign an informed consent document indicating their understanding of the investigational nature and the risks of this study before any protocol related studies are performed. Patients under the age of 18 but who are age 13 or older will be asked to sign an assent document prior to participation.
• EXCLUSION CRITERIA:
• • - Subjects whose co-morbidities preclude surgical intervention.